ID: ALA606292

Max Phase: Preclinical

Molecular Formula: C11H20N5O14P3

Molecular Weight: 539.22

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CN1CN(C2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@H](O)[C@@H]2O)c2nc(N)nc(O)c21

Standard InChI:  InChI=1S/C11H20N5O14P3/c1-15-3-16(8-5(15)9(19)14-11(12)13-8)10-7(18)6(17)4(28-10)2-27-32(23,24)30-33(25,26)29-31(20,21)22/h4,6-7,10,17-18H,2-3H2,1H3,(H,23,24)(H,25,26)(H2,20,21,22)(H3,12,13,14,19)/t4-,6-,7-,10?/m0/s1

Standard InChI Key:  BUJQMJUTTBGELS-VKZRYZQFSA-N

Associated Targets(Human)

Transforming protein p21/H-Ras-1 138 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 539.22Molecular Weight (Monoisotopic): 539.0220AlogP: -2.23#Rotatable Bonds: 8
Polar Surface Area: 288.02Molecular Species: ACIDHBA: 15HBD: 8
#RO5 Violations: 3HBA (Lipinski): 19HBD (Lipinski): 9#RO5 Violations (Lipinski): 3
CX Acidic pKa: 0.89CX Basic pKa: 3.87CX LogP: -3.80CX LogD: -9.22
Aromatic Rings: 1Heavy Atoms: 33QED Weighted: 0.16Np Likeness Score: 1.09

References

1. Noonan T, Brown N, Dudycz L, Wright G..  (1991)  Interaction of GTP derivatives with cellular and oncogenic ras-p21 proteins.,  34  (4): [PMID:2016705] [10.1021/jm00108a010]

Source